1,25-dihydroxycholesterol treatment of long-term haemodialysed patients with renal osteodystrophy.
Renal osteodystrophy still poses major problems in the management of chronic renal failure, though it had been extensively studied over the last years. The present therapeutic possibilities - massive-dose vitamin D, aluminium hydroxide and supplementary Ca-intake, administration of active vitamin D metabolites - are discussed in the light of personal observations.
D000328:Adult; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy*; D004100:Dihydroxycholecalciferols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D013997:Time Factors
D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols